Poseida Therapeutics | IPO Presentation Deck | 34 slides · page 20 of 34
The slide compares autologous (101) vs allogeneic (ALLO1) CAR-T therapy efficacy in tumor reduction.
Pitch deck · traction · show_traction · sparse density
Slide locked Sign in to view
Slide schematic 3/3
chart 2/2 title 1/1
Components 3
line line headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.